Overview

Metabolic Effects of Paricalcitol

Status:
Completed

Trial end date:
2011-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if treatment with paricalcitol, an active form of vitamin D, has beneficial effects on metabolic abnormalities in people with stage 3-4 Chronic Kidney Disease (CKD).

Phase:

Phase 2

Details

Lead Sponsor:

University of Washington

Collaborator:

Abbott

Treatments:

Ergocalciferols